Home›Trial›NCT06959225

🔬NCT06959225Phase 3RECRUITING

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)

Study Summary

The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa.

Conditions

Hidradenitis Suppurativa

Interventions / Drugs

Ruxolitinib Cream Vehicle Cream

View on ClinicalTrials.gov ↗

Sponsor

Incyte Corporation

Study Details

Enrollment550 participants

Primary Completion—

Lead SponsorIncyte Corporation

Data Retrieved2026-04-11 02:55:29.647730+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.